Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions

Developmental Genetics

Volumn 19, Issue 2, 1996, Pages 131-138

  Wright, Woodring E ^a,b   Dac Korytko, Ia ^a   Farmer, Karen ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Parker College of Chiropractic   (United States)

Author keywords

enhancers; Myogenesis; myogenin antibodies; transcription factors

Indexed keywords

DNA; EPITOPE; MONOCLONAL ANTIBODY; MYOGENIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BINDING AFFINITY; DIMERIZATION; MOLECULAR DYNAMICS; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE;

ANIMALS; ANTIBODIES, MONOCLONAL; DIMERIZATION; DNA; DNA-BINDING PROTEINS; EPITOPES; HELIX-LOOP-HELIX MOTIFS; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED BALB C; MYOGENIN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN HYBRIDIZATION; RATS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0029830868     PISSN: 0192253X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6408(1996)19:2<131::AID-DVG4>3.0.CO;2-A     Document Type: Article

References (25)

1. Braun T, Arnold HH (1991): The four human muscle regulatory helix-loop-helix proteins Myf3 to Myf-6 exhibit similar heterodimerization and DNA-binding properties. Nucleic Acids Res 19:5645-5651.
2. Braun T, Arnold HH (1995): Inactivation of myf-6 and myf-5 leads to alterations of skeletal muscle development. EMBO J 14:1176-1186.
3. Braun T, Rudnicki MA, Arnold HH, Jaenisch R (1992): Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71:369-382.
4. Brodsky FM (1985): Clathrin structure characterized with monoclonal antibodies. 1. Analysis of multiple antigenic sites. J Cell Biol 101:2047-2054.
5. Buckingham M (1994): Molecular biology of muscle development. Cell 78:15-21.
6. Cusella-De Angeles MG, Lyons G, Sonnino C, De Angelis L, Vivarelli E, Wright WE, Molinaro M, Bouchè M, Buckingham M, Cossu G (1992): MyoD1, Myogenin independent differentiation of primordial myoblasts in somites. J Cell Biol 116:1243-1255.
7. Edmondson DG, Olson EN (1989): A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 3:628-640.
8. Farmer K, Catala F, Wright WE (1992): Alternative homomeric structures affect myogenin DNA binding activity. J Biol Chem 267: 5631-5636.
9. Funk WD, Wright WE (1992): CASTing for multicomponent complexes: Myogenin interacts with bHLH, NF-1, MEF2 and other factors. Proc Natl Acad Sci USA 89:9484-9488.
10. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, Klein WH (1993): Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
11. Lassar AB, Munsterberg A (1994): Wiring diagrams: Regulatory circuits and the control of skeletal myogenesis. Curr Opin Cell Biol 6:432-442.
12. Ma PCM, Rould MA, Weintraub H, Pabo CO (1994): Crystal structure of MyoD bHLH domain-DNA complex: Perspectives on DNA recognition and implications for transcriptional activation. Cell 77: 451-459.
13. Montarras D, Chelly J, Bober E, Arnold H, Ott MO, Gros F, Pinset C (1991): Developmental patterns in the expression of Myf5, MyoD, myogenin and MRF4 during myogenesis. New Biol 3:592-600.
14. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I, Nabeshima Y (1993): Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364:532-535.
15. Patapoutian A, Yoon JK, Miner JH, Wang S, Stark K, Wold B (1995): Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development 121:3347-3358.
16. Rudnicki MA, Braun T, Hinuma S, Jaenisch R (1992): Inactivation of MyoD in mice leads to upregulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390.
17. Rudnicki MA, Schnegelsberg P, Stead RH, Braun T, Arnold HH, Jaenisch R (1993): MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1360.
18. Sasspon D, Lyons G, Wright WE, Lin VK, Lassar AB, Weintraub H, Buckingham M (1989): Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature 341:303-307.
19. Smith DB, Johnson SJ (1988): Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
20. Smith TH, Block NE, Rhodes SJ, Konieczny SF, Miller JB (1993): A unique pattern of expression of the four muscle regulatory factor proteins distinguishes somitic from embryonic, fetal, and newborn myogenic cells. Development 117:1125-1133.
21. Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM (1995): Expression of myogenic regulatory protein (myogenin and myoD1) in small blue round cell tumors of childhood. Am J Pathol 147:1799-1810.
22. Wright WE, Sassoon DA, Lin VK (1989): Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607-617.
23. Wright WE, Bender M, Funk W (1991): CASTing for the myogenin consensus binding site. Mol Cell Biol 11:4104-4110.
24. Yutzey KE, Rhodes SJ, Konieczny SF (1990): Differential trans activation associated with the muscle regulatory factor MyoD1, myogenin, and MRF4. Mol Cell Biol 10:3934-3944.
25. Zhang W, Behringer RR, Olson EN (1995): Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev 9:1388-1399.